Skip to main content
Clinical Trials/NCT02701361
NCT02701361
Completed
Not Applicable

Mobile Mindfulness to Improve Psychological Distress After Critical Illness

Duke University2 sites in 1 country90 target enrollmentMarch 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Psychological Distress
Sponsor
Duke University
Enrollment
90
Locations
2
Primary Endpoint
Percent of Eligible Participants Who Provide Informed Consent and Were Randomized
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Many survivors of the intensive care unit (ICU) suffer from persistent symptoms of depression, anxiety, and post-traumatic stress disorder (PTSD). In this study, the investigators will test the impact of mindfulness to address this distress.

Detailed Description

A majority of the \>1 million people who require life support in an intensive care unit (ICU) now survive. As survival has improved however, growing numbers suffer not only from subsequent physical disability, but also persistent symptoms of depression, anxiety, and post-traumatic stress disorder (PTSD). Few interventions address ICU survivors' psychological distress. Fewer still address the physical, geographical, and logistical barriers to receiving post-discharge support that medically ill populations encounter. Consequently, this population suffers with an unmet need of great public health importance. Mindfulness is an adaptable self-regulation practice that alleviates psychological distress symptoms using a variety of meditative techniques, typically taught face-to face over months. As an extension of standard mindfulness practices, the investigators developed a telephone-/web-delivered mobile mindfulness-based training (mMBT) system informed by ICU survivors' input that could address medically ill patients' delivery barriers. The investigators' recent pilot study demonstrated early support for mMBT's feasibility and acceptability, now with enhanced content and electronic patient-reported outcomes capability. The investigators' early work on mMBT, while promising, identified key knowledge gaps in population targeting, plausible ranges of psychological distress estimates relevant to study design, and assurance of acceptability that must be addressed before a definitive clinical trial is conducted. Therefore, the study team proposes a 2-year pilot study in which 90 ICU survivors are randomized to an education control, 'standard' telephone sessions of mMBT, or self-directed / app-based mMBT. A mixed methods approach will be used to determine treatment effect.

Registry
clinicaltrials.gov
Start Date
March 2016
End Date
July 5, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Percent of Eligible Participants Who Provide Informed Consent and Were Randomized

Time Frame: randomization

Percent of eligible participants who provide informed consent and were randomized. A measure of feasibility. Target is 60%.

Client Satisfaction Questionnaire (CSQ) Score

Time Frame: 1 month post-randomization

Acceptability was measured with the adapted Client Satisfaction Questionnaire (CSQ), which assesses credibility and satisfaction (range 9 \[low, a worse outcome\] to 36 \[highest, a better outcome\]). Target is mean score \>10.

Percent of Randomized Participants Who Drop Out of Study

Time Frame: baseline, end of study (approx. 4 months)

A feasibility measure. Target is 20% or less.

Percentage of Self-directed MBT Sessions Attended by Eligible Participants

Time Frame: baseline, end of study (approx. 4 months)

A feasibility measure. Target is 50% among those who neither dropped out nor died.

Percent of Eligible Participants Who Provided Consent

Time Frame: pre-randomization

Percent of eligible participants who provided consent. Because this includes eligible yet not-as-yet randomized participants, there are no study arm differences analyzed. This is a feasibility measure. Target is 70%.

Percent of Participants Who Have Neither Dropped Out Nor Died Who Complete Telephone Interviews

Time Frame: baseline, end of study (approx. 4 months)

Percent of participants who have neither dropped out nor died who complete telephone interviews. A feasibility measure. Target is 75%.

Percent of Participants in the Self-directed MBT Group Who Complete Weekly Surveys

Time Frame: baseline, end of study (approx. 4 months)

A feasibility measure. Target is 60%. Note that this is for completion of ALL FOUR weekly surveys.

Number of Participant Clicks on Study Website

Time Frame: baseline, end of study (approx. 4 months)

A usability measure obtained using Google Analytics.

System Usability Scale (SUS)

Time Frame: 1 month post-randomization

Usability of the mobile app was assessed with open-ended participant feedback and with the 10-item System Usability Scale (SUS; 0 \[lowest\] to 100 \[highest\]). A SUS score above a 68 would be considered above average and anything below 68 is below average.

Visual Analog Satisfaction Scale

Time Frame: after intervention completion, up to 8 weeks post-randomization

A measure of acceptability of the intervention. Target mean score is 75% or greater.

Secondary Outcomes

  • Change in Psychological Distress Symptoms as Measured by the GAD-7(Between randomization and 3 months post-randomization)
  • Change in Psychological Distress Symptoms as Measured by the Patient Health Questionnaire (PHQ) Scale(Between randomization and 3 months post-randomization)
  • Change in Distress Associated With Physical Symptoms(Between randomization and 3 months post-randomization)
  • Change in Mindfulness Skills(Between randomization and 3 months post-randomization)
  • Change in Psychological Distress Symptoms as Measured by the PTSS(Between randomization and 3 months post-randomization)
  • Change in the Avoidance Domain of the Brief COPE Scale(Between randomization and 3 months post-randomization)

Study Sites (2)

Loading locations...

Similar Trials